Objective: Elevated blood pressure is an important risk factor for cardiovascular disease and stroke. Several studies have demonstrated that physical exercise reduces blood pressure levels in hypertensive subjects and improves control of several well-known risk factors for atherosclerosis such as diabetes mellitus, blood lipid profile and obesity. Our group attempted to evaluate if an exercise program based on periodic controlled fast walking sessions would reduce blood pressure levels in hypertensive subjects.
and important risk factor for cardiovascular disease and stroke. Because drug therapy for hypertension effectively reduces the risk of stroke and coronary disease, efforts to control BP levels and correlated diseases have concentrated on pharmacological therapy. Still, despite the common use of anti-hypertensive medications, rates of hypertension control remain sub-optimal. 1, 2 Lifestyle modifications such as adjuvant therapy in medicationtreated hypertension are recommended by guidelines, 3 yet there are considerable gaps in our knowledge about the effects of therapies centered on behavioral modifications.
Several studies regarding the relationship between BP levels and physical exercise have focused primarily on dynamic aerobic type exercise. [4] [5] [6] [7] This type of exercise requires a prolonged period of engagement and involves a large number of muscles. Aerobic exercise is the most recommended strategy for general health promotion. 5, 6 In recent years, more emphasis has been placed on resistive exercise, with the same objective. Resistive training consists of local muscle work with overloads, such as weights, bars or clamps, performed with moderate weights. Frequent repetitions alternating with pauses are characteristic; the essential element is discontinuous exertion. [8] [9] [10] Resistive training is currently used in programs of cardiac rehabilitation. When practiced under appropriate supervision, it leads to significant benefits with low risks. 11 In relation to BP reduction, a meta-analysis with normotensive and hypertensive individuals reported a mean 3% reduction in systolic blood pressure (SBP) and a 4% reduction in diastolic blood pressure (DBP) in both groups, with no changes in body weight or resting heart rate, after dynamic resistance exercise. 12 Promoting adjuvant therapy based on physical exercise to a large number of subjects, as required by recent guidelines, not only entails a considerable economic investment, but also requires adequate technical support and continuing supervision of trained physiotherapists. In addition, the increasing use of physical training, especially with older people, is challenged by potential obstacles with respect to pathologic conditions that may limit or prohibit certain types of physical activity. These issues contribute to less use of these important non-pharmacological interventions, both on hypertensive patients and on non-hypertensive high-risk subjects than is expected.
The benefits of physical activity programs centered on walking are well documented: walking is inversely associated with total mortality, 13 faster walking pace was inversely associated with cardiovascular disease and total mortality independently of the time spent walking, 14 and this inverse association was not explained by other cardiovascular risk factors. [13] [14] [15] Specifically in relation to walking activity for hypertensive subjects, Iwane et al. demonstrated that walking 10,000 steps per day or more, irrespective of exercise intensity or duration, is effective in lowering BP, increasing exercise capacity, and reducing sympathetic nerve activity in hypertensive patients. 16 On this basis, our group performed this study with the objective of examining if physical activity obtained through a specific mobility program might lead to an improvement of blood pressure levels in hypertensive well-treated patients, by evaluating BP levels through 24-hour ambulatory blood pressure monitoring (ABPM). 4 3 as an average value obtained with 24 hour Ambulatory Blood Pressure Monitoring (ABPM) performed on admission.
ABPM was performed using a TM -2430 Recorder by A & D Company Limited of Tokyo, Japan. This device provides an oscillometric record. Our recorders was previously validated and recommended for clinical use. 21 The monitoring equipment was arbitrarily applied at 8:00 AM. The cuff was fixed to the non-dominant arm, and three blood pressure readings were taken concomitantly with sphygmomanometer measurements to ensure that the average of the two sets of values did not differ by >5 mmHg. The device was set to measure blood pressure at 15 minute intervals during the day (6-10 PM) and at 30 minute intervals during the night (10 PM-6 AM). During the 24 hours of examination, the patient was informed to hold the arm immobile at the time of measurements, to keep a diary of daily activities and to return to the hospital 24 hours later. The monitoring was always done on a working day and during the normal intake of the usual anti-hypertensive treatment. The patients had no access to the ambulatory blood pressure values. Each of the ambulatory blood pressure devices available for the study was checked monthly.
Measurements recorded during the 24-hour period were stored on a personal computer and screened as follows: a 24-hour record was rejected for analysis if more than one-third of potential day and night measurements were absent or invalid (minimum number of request records per day: 18, per night: 8). 22 The ambulatory BP values used for statistical analysis were expressed as 24-hour average systolic and diastolic pressures. To better analyze the pressure profile during the 24 hours, daytime was arbitrarily divided into three periods: 7-12 AM, 12 AM-5 PM, 5-10 PM. Night-time was analyzed as a single period (10 PM-7 AM). For each of the four resultant periods, average values of SBP and DBP were calculated. When the average values of different periods fell into different categories (according to ESH -ESC Guidelines), 3 the higher category was selected to classify the individual's blood pressure status and only patients with one or more periods falling in stage I systolic and diastolic pressure were enrolled.
For all subjects, the initial study procedure included a comprehensive medical history, complete physical examination, blood biochemical examinations (total cholesterol, triglyceride, creatinine, urea nitrogen, fibrinogen, fasting glucose, sodium, potassium, C-reactive protein, uric acid), and assessment of anti-hypertensive drug treatment. The average duration of hypertension in the enrolled population was 4.3 ± 7.2 years.
All enrolled patients were treated with anti-hypertensive drugs. The treatment consisted of commonly available drugs including b-adrenergic-blocking drugs, calcium channel antagonists, ACE inhibitors, a-adrenergic-blocking drugs, Angiotensin II receptor blockers, and thiazide diuretics; alone or in combination. Subjects enrolled throughout the duration of the study continued taking the same anti-hypertensive drugs at the same dosage as before. No medication changes were allowed during the course of the study. The last allowable change in medication was fixed two months prior to onset of our study.
Patients with secondary hypertension were excluded. All subjects enrolled were non-smoking and did not use tobacco in any form.
The presence of previous cardiovascular events (more than six months) did not constitute an exclusion criterion in subjects maintaining their normal physical and working activities. In contrast, the presence of electrocardiographic evidence of cardiac arrhythmias, or clinical and/or echocardiographic evidence of cardiac heart failure (EF <50%) 19 was considered an exclusion criterion.
The presence of obesity, defined as Body Mass Index >30 Kg/m 2 calculated using weight and height measurements obtained during the clinical examination (body weight/height 2 ), according to the classification system proposed by International Obesity Task Force of World health Organization, 20 also constituted an exclusion criterion. The presence of other diseases, through the clinical history or in biochemical values, in subjects without limitations of normal physical activity did not constitute an exclusion criterion.
Usual physical activity was assessed through specific questions asked while taking the medical history. The population enrolled was composed of sedentary people: subjects recruited were considered sedentary in relation to a mean distance covered in a day <1 km. 16 
Mobility Program and Physical Training
The mobility program proposed to our patients was a structured physical intervention centered on fast walking supervised by an experienced physiotherapist. The sessions were performed on average three times a week, on non-consecutive days, for a total of six weeks. Each session included a warm-up phase of stretching the calf, hamstring and upper limb muscles, followed by a period of fast walking.
To assess the walking speed constituting fast walking for every subject, the first step consisted of determining, for every patient, the self-selected walking speed. With this aim, all participants were invited to walk on a ground-level 20-meter walkway. They were instructed to walk at your normal comfortable speed right to the end of the walkway. Following one familiarization walk, the self-selected walking speed for each subject (meters/min) was calculated over the middle 10 meters of the walkway using a stopwatch. To this self-selected speed, that is assimilable to the walking speed considered comfortable for every subject and measured as described (meters/min), a mean of 40% was added to obtain a value comparable to fast walking for every subject, and corresponding hence to 140% of the naturally selected walking speed for every patient.
Groups homogeneous for walking speed were created and every group walked for 1000 meters on a ground-level 20 meter walkway. After every session a cool-down period was prescribed.
After the six weeks of mobility program, a 24 h ABPM was repeated.
Statistical Analysis
The results in the tables are expressed as mean values ± standard deviation.
Statistic analyses were performed with the Student's paired t-test for comparison of changes in parameters within a group between baseline and after mobility program and physical training. The values of mean ABPM measurements from each patient in every period considered were used for the calculation. Systolic and diastolic blood pressure values were analyzed separately.
RESULTS
Of the 189 patients enrolled, 21 subjects did not complete the training program: six subjects withdrew due to medical problems (four for orthopedic problems, one for gout, one for lower intestinal acute bleeding), 15 subjects withdrew due to lack of motivation. Consequently, data analyses were performed on the 168 subjects that completed the exercise period. In relation to ABPM records all the measurements at baseline and after exercise answered the required characteristics of more than 80% valid recordings.
Age and anthropometric characteristics are shown in Table 1 . Table 1 also shows the non-significant decrease of body weight and BMI value in comparison with the end of the six weeks of training. Table 2 describes ABPM mean values of blood pressure and heart rate obtained during 24 hours, and during the four periods which made up the 24 hours.
Six weeks of the mobility program caused a statistically significant reduction both in SBP and in DBP. This reduction is evident in 24 hours and in the three daytime periods. No differences were found in BP values during sleep between baseline and after exercise. No differences were found on mean values of heart rate comparing the values before and after the mobility program.
On the basis of ABPM data collected, all 168 subjects completing the program were considered dippers (nocturnal dipping was defined as a night-time reduction in average SBP and DBP >10% compared to average daytime values) according to current classification of ABPM measures in hypertensive subjects. 23 This characteristic, to which several studies assign a pivotal role to the development of some expressions of organ damage such as left ventricular hypertrophy (LVH), and carotid intima-media (IM) thickness, has great prognostic relevance. 22, [24] [25] [26] [27] After the six weeks of training, all the subjects examined maintained the dipper pattern of nocturnal BP.
When the analysis of the main biochemical values were measured, compared with the end of the walking program, they showed a trend in reduction similar to what was previously reported in the literature, especially for fasting glucose, total serum cholesterol and triglyceride, without reaching statistical significance. At baseline mean total cholesterol level was 207.5 ± 40.1 mg/dl versus 199.9 ± 33.7 after exercise; mean triglyceride level was 139.2 ± 39.7 versus 135.3 ± 36.5; mean Fasting Glucose was 94.1 ± 8.9 mg/dl versus 90.9 ± 10.2; mean fibrinogen was 132.1 ± 65.2 mg/dl versus 131.9 ± 71.0; mean 
DISCUSSION
The results of our study clearly indicate that a sixweek walking program, in association to anti-hypertensive therapy, lead to a statistically significant reduction of both SBP and DBP levels, even in stage I hypertensive non-obese patients. The determination of change of mean BP levels can effectively be performed by two ABPM recordings, before and after the exercise program. The reduction of BP levels observed in our study, reached statistical significance during all the daytime periods analyzed, not being present during nighttime. No differences were found between men and women. Our data do not confirm existing reports in which exercise training in women may reduce BP more than in men. 28 Use of ESH clinical classification of hypertension to standardize results obtained by 24-hour ABPM has been validated by a recent trial, in which clinic and ambulatory BP determination were compared. 18 The authors demonstrated that ambulatory BP is significantly lower than clinic BP in patients with moderate to severe hypertension and that the disparity between both methods increased with the increase of clinic BP values. Nevertheless, different stages of hypertension could be identified with ABPM according the recent guidelines of clinic BP. Hence 24-hour ambulatory BP data are useful not only to confirm the diagnosis of hypertension but also to set the seriousness of hypertensive disease, providing a relevant prognostic value. 18, 29, 30 On this basis we decided to apply ESH classification of hypertension to our results.
Most trials of non-pharmacological therapy have been conducted on individuals who are not already taking anti-hypertensive medications. In our study, physical exercise was added to pre-existent pharmacological therapy, observing an additive benefit. Additivity of effects of physical exercise and pharmacological therapy is plausible, that is, non-pharmacological therapy could reduce blood pressure to a lesser extent in persons already on drug therapy than in persons not on drug therapy. This occurrence seems related to the hypothesis that physical exercise modifies biochemical and metabolic pathways allowing the expression of an optimal biologic action to drugs. Our patients were under therapy with anti-hypertensive drugs without reaching the BP levels recommended by guidelines on hypertension management. 3 Regular exercise helped to reduce BP levels, confirming an approach in which drugs are flanked by behavioral and dietetic rules. Many authors share our global approach to treatment of hypertension, not only based on drug therapy, but also testing BP levels after behavioral and lifestyle modifications (diet, weight loss, moderate alcohol consumption) and obtaining very interesting results. [31] [32] [33] [34] [35] [36] The benefit of lowered BP levels achieved through exercise therapy could be amplified when considering of the already demonstrated favorable effects of training on several metabolic parameters such as total, LDL, and HDL cholesterol serum levels and insulin-resistance. [37] [38] [39] [40] [41] [42] [43] All these positive effects lead to a reduction of overall cardiovascular risk status, as a consequence of favorable effects on more elements involved in the determination of risk (blood lipid profile, insulin-resistance, obesity, BP levels). Some evidence also indicates that exercise training in hypertensive patients may result in regression of pathological left ventricular hypertrophy. 30 A further validation of the links existing among the metabolic parameters and of the benefits of exercise therapy on all of them has been given by the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III in the guidelines of the Metabolic Syndrome (MS). Following these guidelines, MS is the result of the presence in the same subjects of three conditions among hypertension: diabetes mellitus, obesity, hyper-trigliceridemia, and low HDL cholesterol levels. There is consensus that non-pharmacologic treatment of MS should be centered on weight loss and improvement of the underlying insulin-resistance through lifestyle modification, firstly by increasing physical activity. 44 In our study we wanted to make a comparison between the main metabolic parameters involved in MS evaluated at baseline and after exercise program. The differences found after the six weeks were not statistically significant. There are two potential reasons for this: the duration of the study was only a six-week walking program, and we choose to maintain previous dietary prescriptions for subjects without providing new indications with the aim of reducing caloric and/or lipid intake. One of our objectives, in fact, was to emphasize the role of exercise on lowering blood pressure levels independently of the evident effect on reduction of body weight, by recruiting subjects without obesity.
There are many pathological-physiological hypotheses proposed to explain the anti-hypertensive mechanism of exercise. Arakawa et al. 45 demonstrated that the antihypertensive mechanism of exercise is multi-factorial, involving sympathicolythic as well as diuretic actions through activation of relevant metabolic pathways; that is, a decrease in endogenous ouabaine-like substances and an increase in plasma taurine, prostaglandin E and urinary dopamine, and kallikrein excretion. This would suggest that abnormalities of autonomic control and vaso-reactivity might be improved after exercise conditioning. It has also been confirmed that reduction in sympathetic nervous tonus plays an important role in anti-hypertensive mechanism. 16 Consistent with this hypothesis, the benefit in lowering BP levels in our population was greater during the day, while non-significant changes were observed during the night. At night the sympathetic nervous activity is low in normal and in essential hypertensive subjects. 46 During the day, however, the overall sympathetic nervous activity is higher and the effectiveness of exercise training could thus be more pronounced. Reduction of sympathetic activity could determine pressure loss also by reduction of peripheral vascular resistance. 47 Our results support the recommendation that exercise training is an important initial or adjunctive step in the treatment of individuals with mild elevations of BP levels that is highly efficacious in addiction to pharmacological therapy. These benefits are achieved even after six weeks of exercise. It would be interesting to evaluate changes of BP levels after a longer follow-up, according to the evidence provided by other trials that suggest how BP reduction persists as long as participants adhere to therapy. 48 Another possible development could be the analysis of training effects on non-dipper patients, to evaluate the effect of exercise in this sub-group of hypertensive patients in which the abnormalities of BP circadian cycle are clearer, and the night-time blood pressure levels are higher.
